Literature DB >> 16636900

Cytidine and uridine increase striatal CDP-choline levels without decreasing acetylcholine synthesis or release.

Ismail H Ulus1, Carol J Watkins, Mehmet Cansev, Richard J Wurtman.   

Abstract

AIMS: Treatments that increase acetylcholine release from brain slices decrease the synthesis of phosphatidylcholine by, and its levels in, the slices. We examined whether adding cytidine or uridine to the slice medium, which increases the utilization of choline to form phospholipids, also decreases acetylcholine levels and release.
METHODS: We incubated rat brain slices with or without cytidine or uridine (both 25-400 microM), and with or without choline (20-40 microM), and measured the spontaneous and potassium-evoked release of acetylcholine.
RESULTS: Striatal slices stimulated for 2 h released 2650+/-365 pmol of acetylcholine per mg protein when incubated without choline, or 4600+/-450 pmol/mg protein acetylcholine when incubated with choline (20 microM). Adding cytidine or uridine (both 25-400 microM) to the media failed to affect acetylcholine release whether or not choline was also added, even though the pyrimidines (400 microM) did enhance choline;s utilization to form CDP-choline by 89 or 61%, respectively. The pyrimidines also had no effect on acetylcholine release from hippocampal and cortical slices. Cytidine or uridine also failed to affect acetylcholine levels in striatal slices, nor choline transport into striatal synaptosomes.
CONCLUSION: These data show that cytidine and uridine can stimulate brain phosphatide synthesis without diminishing acetylcholine synthesis or release.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636900     DOI: 10.1007/s10571-006-9004-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  19 in total

1.  Control of membrane phosphatidylcholine biosynthesis by diacylglycerol levels in neuronal cells undergoing neurite outgrowth.

Authors:  W Araki; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Acute choline supplementation in vivo enhances acetylcholine synthesis in vitro when neurotransmitter release is increased by potassium.

Authors:  L Wecker; G Cawley; S Rothermel
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

3.  Acetylcholine synthesis in rat neostriatal slices.

Authors:  M H Weiler; U Misgeld; I J Bak; D J Jenden
Journal:  Brain Res       Date:  1979-11-02       Impact factor: 3.252

4.  Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells.

Authors:  U Ingrid Richardson; Carol J Watkins; Celine Pierre; Ismael H Ulus; Richard J Wurtman
Journal:  Brain Res       Date:  2003-05-09       Impact factor: 3.252

5.  Effect of oral CDP-choline on plasma choline and uridine levels in humans.

Authors:  R J Wurtman; M Regan; I Ulus; L Yu
Journal:  Biochem Pharmacol       Date:  2000-10-01       Impact factor: 5.858

6.  Effects of electrical stimulation and choline availability on the release and contents of acetylcholine and choline in superfused slices from rat striatum.

Authors:  J C Maire; R J Wurtman
Journal:  J Physiol (Paris)       Date:  1985

7.  Oral uridine-5'-monophosphate (UMP) increases brain CDP-choline levels in gerbils.

Authors:  Mehmet Cansev; Carol J Watkins; Eline M van der Beek; Richard J Wurtman
Journal:  Brain Res       Date:  2005-08-29       Impact factor: 3.252

8.  Choline's phosphorylation in rat striatal slices is regulated by the activity of cholinergic neurons.

Authors:  S A Farber; V Savci; A Wei; B E Slack; R J Wurtman
Journal:  Brain Res       Date:  1996-06-03       Impact factor: 3.252

Review 9.  The choline transporter resurfaces: new roles for synaptic vesicles?

Authors:  Shawn M Ferguson; Randy D Blakely
Journal:  Mol Interv       Date:  2004-02

10.  Effect of cytidine on membrane phospholipid synthesis in rat striatal slices.

Authors:  V Savci; R J Wurtman
Journal:  J Neurochem       Date:  1995-01       Impact factor: 5.372

View more
  7 in total

1.  Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T.

Authors:  Nivedita Agarwal; Young-Hoon Sung; J Eric Jensen; Grace daCunha; David Harper; David Olson; Perry F Renshaw
Journal:  Bipolar Disord       Date:  2010-12       Impact factor: 6.744

Review 2.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 3.  Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.

Authors:  Mehmet Cansev; Richard J Wurtman; Toshimasa Sakamoto; Ismail H Ulus
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

4.  Synaptogenesis: Modulation by Availability of Membrane Phospholipid Precursors.

Authors:  Mehmet Cansev
Journal:  Neuromolecular Med       Date:  2016-06-01       Impact factor: 3.843

5.  Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control.

Authors:  Yolandi van der Merwe; Matthew C Murphy; Jeffrey R Sims; Muneeb A Faiq; Xiao-Ling Yang; Leon C Ho; Ian P Conner; Yu Yu; Christopher K Leung; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

Review 6.  Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease.

Authors:  Dhaval Patel; Stephan N Witt
Journal:  Oxid Med Cell Longev       Date:  2017-07-12       Impact factor: 6.543

7.  Cytidine 5'-diphosphocholine administration prevents peripheral neuropathic pain after sciatic nerve crush injury in rats.

Authors:  Dessy R Emril; Samekto Wibowo; Lucas Meliala; Rina Susilowati
Journal:  J Pain Res       Date:  2016-05-23       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.